VIR — Vir Biotechnology Inc. price, chart and key statistics

Price data

Price

$9.96

YTD price return

+65.17%

YTD total return

+65.17%

Next earnings

Nov 4, 2026

Market cap

1.7B2019-12 1.4B2026-10 1.7B+22.1% over the window

Enterprise value

1.3B

Shares outstanding

169.2M2018-12 8.9M2026-06 169.2M+1810.1% over the window

52W low

$4.82

52W high

$12.00

From 52W high

-17.00%

From 52W low

+106.85%

52W range

72%

Volume

Rel volume

0.81×

30D volume

2.1M

30D $ vol

23.5M

Fundamentals

Sales (ttm)

303.2M2017-12 2.7M2026-06 303.2M+11097.5% over the window

Sales/share

$1.792018-12 $1.202026-06 $1.79+48.8% over the window

EPS (ttm)

-$1.692019-12 -$5.762026-06 -$1.69-70.6% over the window

FCF (ttm)

-203.6M2017-12 -69.1M2026-06 -203.6M+194.5% over the window

FCF/share

-$1.202018-12 -$11.552026-06 -$1.20-89.6% over the window

Book value/share

$5.812018-06 -$13.812026-06 $5.81-142.1% over the window

Net margin

-83.00%2017-12 -2579.5%2026-06 -83.0%-96.8% over the window

ROE

-25.62%2019-12 -41.2%2026-06 -25.6%-37.8% over the window

ROA

-20.72%2018-12 -60.5%2026-06 -20.7%-65.7% over the window

Current ratio

6.042018-12 2.952026-06 6.04+104.7% over the window

Growth (CAGR, ttm) · 10Y

Sales

+1498.96%2025-06-30 → 2026-06-3019M → 303.2M (+1495.9% total)-14.82%2023-06-30 → 2026-06-30490.7M → 303.2M (-38.2% total)+10.66%2021-06-30 → 2026-06-30182.7M → 303.2M (+66.0% total)n/a

Shares

+21.83%2025-06-30 → 2026-06-30138.9M → 169.2M (+21.8% total)+8.02%2023-06-30 → 2026-06-30134.3M → 169.2M (+26.0% total)+5.32%2021-06-30 → 2026-06-30130.6M → 169.2M (+29.6% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+1212.48%2025-06-30 → 2026-06-30$0.14 → $1.79 (+1210.2% total)-21.15%2023-06-30 → 2026-06-30$3.66 → $1.79 (-51.0% total)+5.08%2021-06-30 → 2026-06-30$1.40 → $1.79 (+28.1% total)n/a

Book value/share

-14.88%2025-06-30 → 2026-06-30$6.82 → $5.81 (-14.9% total)-24.48%2023-06-30 → 2026-06-30$13.48 → $5.81 (-56.9% total)+0.56%2021-06-30 → 2026-06-30$5.65 → $5.81 (+2.9% total)n/a

Price

+71.79%2025-10-16 → 2026-10-16$5.80 → $9.96 (+71.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+5.34%2023-10-16 → 2026-10-16$8.52 → $9.96 (+16.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-23.92%2021-10-15 → 2026-10-16$39.09 → $9.96 (-74.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+71.79%2025-10-16 → 2026-10-16$5.80 → $9.96 (+71.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.34%2023-10-16 → 2026-10-16$8.52 → $9.96 (+16.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-23.92%2021-10-15 → 2026-10-16$39.09 → $9.96 (-74.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-5.9×2019-12 -7.902026-10 -6.70-15.3% over the window

Fwd P/E

-4.7×

P/S (ttm)Market cap ÷ TTM revenue.

5.6×2019-12 170.652026-10 5.56-96.7% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.7×2019-12 3.262026-10 1.72-47.3% over the window

EV/Sales (ttm)

4.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-12.08%2019-09 -9.4%2026-06 -11.8%+25.0% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 169.2M ÷ 138.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-21.83%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-21.83%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($700.1M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-21.83%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-09 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.7B). Same caveat as the cash buyback yield.

0.00%2019-09 0.0%2026-06 0.0%

Vs own 10Y history

P/S

23rd

P/B

55th